Efizonerimod alfa

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameEfizonerimod alfa
Drug Alias NameefizonerimodMEDI-6383
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 agonistsTumor necrosis factor ligand superfamily member 4 inhibitors
TargetsTumor necrosis factor ligand superfamily member 4Tumor necrosis factor receptor superfamily member 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedimmune
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Llc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A